EUVIMEDEUVIMED entdecken
Crossref

Photodynamic Immunotherapy Using ADU-S100-Modified Nanoparticles to Treat Triple-Negative Breast Cancer

Tong Ge iD, Wenshu Ge, Ludan Zhang iD, Guohui Yu iD, Yi Li iD, Lisha Sun, Fan Dong, Zhi Yao, Lei Shi, Yuguang Wang

Nanomedicine · 2023-04 · 18 (9) · 755-767

DOI: 10.2217/nnm-2022-0299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanomedicine, online erschienen am 12.06.2023. Verfasst von Tong Ge und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Key Laboratory of Immune Microenvironment & Disease of the Educational Ministry of China, Tianjin Key Laboratory of Cellula…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

STING agonists in immunotherapy show great promise and are currently in clinical trials. Combinations of STING agonists with other therapies remain underexplored. This study aimed to combine STING agonist-mediated immunotherapy with photodynamic therapy to treat breast cancer.

Methods

STING agonist (ADU-S100)-functionalized porphyrin-based nanoparticles (NP-AS) were prepared and their antitumor properties in terms of cell apoptosis/necrosis and immune activation in triple-negative breast cancer were evaluated.

Results

NP-AS induced tumor cell apoptosis/necrosis, activated the innate immune response and exhibited useful antitumor effects.

Conclusion

NP-AS effectively treated breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsNanoparticlesNeoplasmsHumansImmunotherapyNecrosisNucleotides, Cyclic

Stichwörter der Autor:innen

STING agonistcGAS/STING pathwayimmune checkpoint blockade therapyimmunotherapyphotodynamic therapy

Substanzen

ADU-S100Nucleotides, Cyclic

Autor:innen und Institutionen

  • Department of Immunology, Key Laboratory of Immune Microenvironment & Disease of the Educational Ministry of China, Tianjin Key Laboratory of Cellular & Molecular Immunology, School of Basic Medical Sciences, Tianjin Me…
  • Center of Digital Dentistry/Department of Prosthodontics, National Center of Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Laboratory for Digital & Material Technology of Stomato…

ORCID-Profile: Tong Ge, Ludan Zhang, Guohui Yu, Yi Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ge, T., Ge, W., Zhang, L., Yu, G., Li, Y., Sun, L., Dong, F., Yao, Z., Shi, L., & Wang, Y. (2023). Photodynamic Immunotherapy Using ADU-S100-Modified Nanoparticles to Treat Triple-Negative Breast Cancer. Nanomedicine, 18(9), 755-767. https://doi.org/10.2217/nnm-2022-0299

Vancouver

Ge T, Ge W, Zhang L, Yu G, Li Y, Sun L, et al. Photodynamic Immunotherapy Using ADU-S100-Modified Nanoparticles to Treat Triple-Negative Breast Cancer. Nanomedicine. 2023;18(9):755-767. doi:10.2217/nnm-2022-0299

BibTeX
@article{Ge2023,
  author = {Ge, Tong and Ge, Wenshu and Zhang, Ludan and Yu, Guohui and Li, Yi and Sun, Lisha and Dong, Fan and Yao, Zhi and Shi, Lei and Wang, Yuguang},
  title = {Photodynamic Immunotherapy Using ADU-S100-Modified Nanoparticles to Treat Triple-Negative Breast Cancer},
  journal = {Nanomedicine},
  year = {2023},
  volume = {18},
  number = {9},
  pages = {755--767},
  doi = {10.2217/nnm-2022-0299}
}
Kostenlos starten →